Coagulation Factors 2011 who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis
Product description
The report Coagulation Factors 2011 who does meet the market needs?A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis provides a description, evaluation and assessment of the recombinant coagulation factor R&D pipelines as of October 2011. The authors analyze and assess the target pipeline for each of the coagulation factors for haemophilia and work out the target profiles of development projects. A market research study was conducted to challenge industrys target profiles and evaluate the sensitivity for pricing.
The report is built upon primary and secondary search for information and use of a proprietary database and news portal. A market survey was conducted among haematologists from haemophilia care centers. In house analysts with experience in biopharmaceutical R&D and business development authored the report and analysed and assessed the findings.
To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/coagulation-factors-2011-who-does-meet-the-market-needs-a-pipeline-assessment-market-survey-and-corporate-benchmark-analysis
Global sales of the five major recombinant products of coagulation factors VIII, IX and VIIa in 2010 were US$ 6.2 bln (with $ conversion rate October 19, 2010). The first Marketing Authorization Application for a novel recombinant coagulation factor has been submitted in the European Union and further novel wild-type and long-acting recombinant coagulation factors VIII, IX and VII are in advanced clinical stages with potential regulatory approvals within the next 2 to 4 years. Given the progress of the pipeline, a concentration process of players has started. First clinical data are available and will guide further definition of R&D in this field.
Scope of the report
- R&D pipeline overview;
- profiles of most promising coagulation factors in the pipeline
- pipeline analysis for each coagulation factor
- evaluation and assessment of protein engineering and drug delivery technologies
- overview and analysis of marketed coagulation factors;
- market research study with haematologists from haemophilia care centers
- corporate product portfolios and R&D pipelines;
- benchmark of competitors regarding achievement of product target profiles
Benefits from the report
- Understand your position in a highly competitive environment
- Learn what haematologists think about your product target profiles
- Understand the market needs
- Know pricing sensitivities for your haemophilia products
- Learn from your competitors
- Challenge your strategy with a view from outside the organization
To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/139871
About Us
MarketResearchReports.Biz is the most comprehensive
collection of market research reports. MarketResearchReports.Biz services are
especially designed to save time and money of our clients. We are a one stop
solution for all your research needs, our main offerings are syndicated
research reports, custom research, subscription access and consulting services.
We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Blog: http://industry-research-reports.blogspot.com/
